Yingting Liu
Changzhou, 213003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
IL-1R2 promotes tumorigenesis and modulates the tumor immune microenvironment in colorectal cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: May 29, 2025
Evaluating IL22RA1 expression as a predictive indicator in human colon cancer progression.
Journal: BMC cancer
Published: January 19, 2025
Tumor-infiltrating CD103+CD8+hnRNPA2B1+ tissue-resident T cells indicate poor prognosis in patients with clear cell renal cell carcinoma.
Journal: Journal of leukocyte biology
Published: December 19, 2024
Tregs ST2 deficiency enhances the abscopal anti-tumor response induced by microwave ablation.
Journal: International immunopharmacology
Published: August 19, 2024
Novel biomarkers: the RUNX family as prognostic predictors in colorectal cancer.
Journal: Frontiers in immunology
Published: May 09, 2024
Precursor exhausted CD8+T cells in colorectal cancer tissues associated with patient's survival and immunotherapy responsiveness.
Journal: Frontiers in immunology
Published: December 27, 2023
TIGIT Blockade Reshapes the Tumor Microenvironment Based on the Single-cell RNA-Sequencing Analysis.
TIGIT Blockade Reshapes the Tumor Microenvironment Based on the Single-cell RNA-Sequencing Analysis.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: July 26, 2023
Prognostic values of tissue-resident CD8+T cells in human hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Journal: World journal of surgical oncology
Published: January 17, 2023
LAG3 blockade coordinates with microwave ablation to promote CD8+ T cell-mediated anti-tumor immunity.
Journal: Journal of translational medicine
Published: June 13, 2022
IL1R2 promotes tumor progression via JAK2/STAT3 pathway in human clear cell renal cell carcinoma.
Journal: Pathology, research and practice
Published: May 20, 2022
Last Updated: 09/26/2026